Medicare Enrolled

Dr. John Willis, M.D.

Rheumatology · Dallas, TX
712 N WASHINGTON AVE, Dallas, TX 75246
2148236503
Registered in NPPES since 2006
NPI: 1093730160 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Willis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Willis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Willis

Dr. John Willis is a rheumatology specialist in Dallas, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Willis received a total of $12,015 from 42 pharmaceutical and/or device companies across 706 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Willis is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $12,015 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,015
Total received (2018-2024)
Avg $1,716/year across 7 years
Top 28% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
706
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$42
2023
$324
2022
$2,125
2021
$3,108
2020
$1,789
2019
$2,275
2018
$2,351

Payments by company (2024)

UCB, Inc.
$42
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,847
AbbVie Inc.
$1,816
Amgen Inc.
$1,745
AbbVie, Inc.
$1,093
Horizon Therapeutics plc
$622
ABBVIE INC.
$539
PFIZER INC.
$481
UCB, Inc.
$433
GlaxoSmithKline, LLC.
$422
Celgene Corporation
$343
Genentech USA, Inc.
$296
Aurinia Pharma U.S., Inc.
$258
Lilly USA, LLC
$248
E.R. Squibb & Sons, L.L.C.
$231
Janssen Biotech, Inc.
$227
Mallinckrodt Hospital Products Inc.
$208
GENZYME CORPORATION
$208
AstraZeneca Pharmaceuticals LP
$205
Mallinckrodt Enterprises LLC
$129
Radius Health, Inc.
$89
Bioventus LLC
$72
Alexion Pharmaceuticals, Inc.
$52
MEDAC PHARMA, INC.
$38
Horizon Pharma plc
$35
Organon LLC
$34
Ferring Pharmaceuticals Inc.
$31
Ultragenyx Pharmaceutical Inc.
$31
Exeltis, USA Inc.
$28
Merck Sharp & Dohme Corporation
$24
Hikma Pharmaceuticals USA
$23
Sobi, Inc
$23
Oxford Immunotec USA Inc
$21
Gilead Sciences, Inc.
$20
DePuy Synthes Sales Inc.
$19
Antares Pharma, Inc.
$19
Flexion Therapeutics, Inc.
$18
Boston Scientific Corporation
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
Avanos Medical
$14
Mission Pharmacal Company
$14
Allergan Inc.
$13
Ironwood Pharmaceuticals, Inc
$13
Top 3 companies account for 45.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AVSOLA · Actemra · BENLYSTA · Binosto · COSENTYX · Cimzia · Crysvita · Durolane · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FARXIGA · GENERAL - PAIN MANAGEMENT · HUMIRA · HYQVIA · Humira · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LINZESS · LUMIGAN · LUPKYNIS · LYRICA · Mitigare · ORENCIA · ORTHOVISC · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · Strensiq · TALTZ · TREMFYA · TRIVISC SODIUM HYALURONATE · TSPOT TB TEST · Tymlos · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Dallas?
Compare rheumatologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
95
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Willis is a rheumatology specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Willis receive payments from pharmaceutical companies?
Yes. Dr. Willis received a total of $12,015 from 42 companies across 706 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Willis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →